We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

Researchers uncover promising evidence that xenon gas, commonly used in anesthesia, may help reduce brain deterioration and ...

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed potential in protecting the brain in studies.

ATx has created groundbreaking drugs for dementia and Alzheimer’s. The Icelandic startup just raised €26mn to advance the ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Mild chronic small vessel disease, or cerebral small vessel disease (CSVD), is an umbrella term for a range of conditions ...